Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hangzhou Aorui Biotechnology

Request full access

Non-invasive diagnostic products for early cancer screening

Hangzhou, ChinaFounded 2018

About Hangzhou Aorui Biotechnology

Hangzhou Aorui Biotechnology, also known as Oriomics, is a life sciences company founded in 2018 and headquartered in Hangzhou, China. The company specializes in developing in-vitro diagnostic products for the early screening and diagnosis of cancer. It utilizes a non-invasive liquid biopsy approach, combining next-generation sequencing (NGS) and PCR multi-omics technology to analyze biomarkers in bodily fluids.

The firm has successfully developed a product for the early detection of liver cancer and is expanding its pipeline to include diagnostics for other high-incidence cancers such as gastric, breast, bowel, pancreatic, and lung cancer, as well as products for detecting multiple cancers simultaneously. The company's technology aims to provide accurate, non-invasive alternatives to traditional diagnostic methods.

Hangzhou Aorui Biotechnology has secured significant funding to support its research and development efforts. The company has raised a total of $15.7M over two funding rounds. Its first funding round was a Series B on January 7, 2022, for $15.7M. A second Series B round for an undisclosed amount occurred on September 11, 2023, with lead investor Fortune Capital and participation from Tao Capital.

Source: Dealroom company data

At a glance

Status
Operational
Employees
2
Open positions
3
Dealroom signal
17.7/100

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Sep 2023 $14M $55M Dachen Caizhi · Tao Capital · Hotgen ↗
SERIES BEquity / VC Jan 2022 $14M $55M Hotgen —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Hangzhou Aorui Biotechnology website traffic

Latest recorded traffic for Hangzhou Aorui Biotechnology is 50 monthly website visits, down 68.8% over the last three months. Hangzhou Aorui Biotechnology's team grew 0% over the past year.

Latest monthly visits50 3-month web change-68.8% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Hangzhou Aorui Biotechnology in the Hangzhou ecosystem

Live from Dealroom

The Hangzhou Aorui Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Hotgen
  • Dachen Caizhi
  • Tao Capital
Employees 2 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hangzhou Aorui Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hangzhou Aorui Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.